University of Arizona - Banner Health Precision Medicine Initiative Cohort Enrollment Center

亚利桑那大学 - 横幅健康精准医学计划队列招生中心

基本信息

  • 批准号:
    9228653
  • 负责人:
  • 金额:
    $ 395.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-06 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT In this grant application, we propose to establish the University of Arizona Health Sciences – Banner Health (UA-Banner) Healthcare Provider Organization (HPO) Enrollment Center for the primary purpose of recruiting the large majority (50-70%) of the American Indians/Alaska Natives (AI/AN) and Hispanics/Latinos (Hisp/Lat) participants required in the NIH Precision Medicine Initiative Cohort Program (PMI-CP) which will initially enroll one million participants. The PMI-CP is a timely development that will facilitate the ability to lever advances in genomics, metabolomics, and health technologies to reduce health disparities which are contributing to excessive suffering, disability, premature death, and economic losses particularly in racial/ethnic minority populations. Today, greater than 20 years after the NIH Revitalization Act, the goal of increasing the participation of minorities in biomedical research remains an unfulfilled dream with participation rates in clinical trials remaining at 0.2% for American Indian/Alaskan Native (AI/AN) and 1-2% for Hisp/Lat; far less than their 1.0% and 17.4% representations in the U.S. population, respectively. Without adequate representation of minorities in research studies, we will continue to practice “Imprecise Medicine” in which research findings from studies conducted almost exclusively in non-Hispanic white populations are extrapolated to racial/ethnic minorities. The UA-Banner proposal is a formal partnership between the University of Arizona and Banner Health serving as the primary healthcare provider for 4.5 million individuals in seven Western States including 60% of the population of Arizona. We will utilize a well-defined potential participant pool of 1.725 million patients across 12 enrollment sites in Arizona, Alaska, and Wyoming to accomplish the following: (1) Enroll >150,000 volunteers, including 7,000 AI/AN, 90,000 Hisp/Lat and 53,000 non-Hispanic Whites, and individuals of other races/ethnicity into the PMI-CP; (2) Implement a comprehensive participant engagement plan that values the participants as “partners in discovery” rather than “research subjects”; (3) Use a secure and robust Enterprise Data Warehouse system to obtain, curate, de-identify, and normalize Electronic Health Records to transmit “core datasets” quarterly to the Coordinating Center (CC) and provide “subgroup” datasets for special studies; and (4) Collaborate with the CC, other HPOs, the participant technologies center, the PMI-CP Biobank, and the Steering Committee to develop and implement protocols and procedures, perform special studies, obtain additional specimens and increase the number and types of data collected. Our targeted enrollment of AI/AN and Hisp/Lat populations into the PMI-CP will bring us closer to one of the President's PMI goals - to reduce ethnic/racial health disparities in the U.S. through the robust participation of the AI/AN and Hisp/Lat populations in PMI-CP special research studies and novel clinical trials as a necessary step to realize the benefits of individualized therapies and tailored preventative strategies in racial/ethnic minority populations.
摘要 在此拨款申请中,我们建议建立亚利桑那大学健康科学-班纳健康 (UA-Banner)医疗保健提供者组织(HPO)招募中心,主要用于招募 绝大多数(50-70%)美国印第安人/阿拉斯加原住民(AI/AN)和西班牙裔/拉丁裔(Hisp/Lat) NIH精准医学倡议队列计划(PMI-CP)所需的参与者,该计划最初将招募 一百万参与者。PMI-CP是一个及时的发展,将促进在以下方面取得进展的能力: 基因组学、代谢组学和健康技术,以减少健康差距, 过度痛苦、残疾、过早死亡和经济损失,特别是在种族/族裔少数群体中 人口。今天,在NIH振兴法案通过20多年后, 少数群体参与生物医学研究仍然是一个未实现的梦想, 美国印第安人/阿拉斯加原住民(AI/AN)的试验保持在0.2%,Hisp/Lat的试验保持在1-2%;远远低于他们的水平。 1.0%和17.4%的代表在美国人口中,分别。如果没有充分的代表性, 在研究中,我们将继续实践“不精确医学”,其中研究结果来自 几乎完全在非西班牙裔白色人群中进行的研究外推至种族/民族 少数群体UA-Banner提案是亚利桑那大学和Banner之间的正式合作伙伴关系 卫生部为西部七个州的450万人提供初级卫生保健服务,包括 亚利桑那州60%的人口。我们将利用一个明确的潜在参与者池172.5万 在亚利桑那州、阿拉斯加州和怀俄明州的12个入组研究中心招募患者,以完成以下任务:(1)入组 > 150,000名志愿者,包括7,000名AI/AN,90,000名Hisp/Lat和53,000名非西班牙裔白人,以及个人 (2)实施全面的参与者参与计划, 将参与者视为“发现的伙伴”而不是“研究对象”;(3)使用安全可靠的 企业数据仓库系统,用于获取、管理、去识别和规范化电子健康记录, 每季度向协调中心传送“核心数据集”,并为特别会议提供“分组”数据集。 研究;以及(4)与CC、其他HPO、参与者技术中心、PMI-CP合作 生物库和指导委员会制定和实施方案和程序, 研究,获得更多的标本,并增加收集的数据的数量和类型。我们的目标 将AI/AN和Hisp/Lat人群纳入PMI-CP将使我们更接近总统的PMI之一 目标-通过AI/AN的积极参与,减少美国的民族/种族健康差距, PMI-CP特殊研究和新型临床试验中的Hisp/Lat人群,作为实现 个体化治疗和量身定制的预防策略在种族/少数民族人群中的益处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Akinlolu Oluseun Ojo其他文献

Akinlolu Oluseun Ojo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Akinlolu Oluseun Ojo', 18)}}的其他基金

A Clinical Trial to Prevent New Onset Diabetes After Transplantation
预防移植后新发糖尿病的临床试验
  • 批准号:
    8162925
  • 财政年份:
    2011
  • 资助金额:
    $ 395.62万
  • 项目类别:
A Clinical Trial to Prevent New Onset Diabetes After Transplantation
预防移植后新发糖尿病的临床试验
  • 批准号:
    8472492
  • 财政年份:
    2011
  • 资助金额:
    $ 395.62万
  • 项目类别:
A Clinical Trial to Prevent New Onset Diabetes After Transplantation
预防移植后新发糖尿病的临床试验
  • 批准号:
    8330867
  • 财政年份:
    2011
  • 资助金额:
    $ 395.62万
  • 项目类别:
A Clinical Trial to Prevent New Onset Diabetes After Transplantation
预防移植后新发糖尿病的临床试验
  • 批准号:
    8677880
  • 财政年份:
    2011
  • 资助金额:
    $ 395.62万
  • 项目类别:
Chronic Renal Insufficiency Cohort (CRIC) Study
慢性肾功能不全队列 (CRIC) 研究
  • 批准号:
    7901940
  • 财政年份:
    2009
  • 资助金额:
    $ 395.62万
  • 项目类别:
HIGH DOSE FOLIC ACID, VITAMINS B6 & B12 ON ARTERIOSCLEROTIC CARDIOVASC OUTCOMES
高剂量叶酸、维生素 B6
  • 批准号:
    7603713
  • 财政年份:
    2007
  • 资助金额:
    $ 395.62万
  • 项目类别:
CHRONIC RENAL INSUFFICIENCY COHORT STUDY (CRIC)
慢性肾功能不全队列研究 (CRIC)
  • 批准号:
    7603738
  • 财政年份:
    2007
  • 资助金额:
    $ 395.62万
  • 项目类别:
CHRONIC RENAL INSUFFICIENCY COHORT STUDY (CRIC)
慢性肾功能不全队列研究 (CRIC)
  • 批准号:
    7376558
  • 财政年份:
    2006
  • 资助金额:
    $ 395.62万
  • 项目类别:
HIGH DOSE FOLIC ACID, VITAMINS B6 & B12 ON ARTERIOSCLEROTIC CARDIOVASC OUTCOMES
高剂量叶酸、维生素 B6
  • 批准号:
    7376516
  • 财政年份:
    2006
  • 资助金额:
    $ 395.62万
  • 项目类别:
Clinical Center: Medical and Quality of Life Outcomes after Live Kidney or Lung D
临床中心:活体肾或肺 D 术后的医疗和生活质量结果
  • 批准号:
    7099088
  • 财政年份:
    2006
  • 资助金额:
    $ 395.62万
  • 项目类别:

相似海外基金

NNA Research: Collaborative Research: Towards resilient water infrastructure in Alaska Native communities through knowledge co-production
NNA 研究:合作研究:通过知识共同生产为阿拉斯加原住民社区打造具有复原力的水基础设施
  • 批准号:
    2220518
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
    Standard Grant
NNA Research: Collaborative Research: Towards resilient water infrastructure in Alaska Native communities through knowledge co-production
NNA 研究:合作研究:通过知识共同生产为阿拉斯加原住民社区打造具有复原力的水基础设施
  • 批准号:
    2220516
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
    Standard Grant
NNA Research: Collaborative Research: Towards resilient water infrastructure in Alaska Native communities through knowledge co-production
NNA 研究:合作研究:通过知识共同生产为阿拉斯加原住民社区打造具有复原力的水基础设施
  • 批准号:
    2220517
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
    Standard Grant
Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people
阿拉斯加原住民结直肠癌肿瘤和免疫微环境的深入分子和细胞分析
  • 批准号:
    10651205
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
Development of an Instrument for Assessment of Indigenous Historical Trauma as a Social Determinant of Health Among American Indian/Alaska Native Populations
开发一种评估土著历史创伤作为美洲印第安人/阿拉斯加原住民健康社会决定因素的工具
  • 批准号:
    10736011
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
Understanding cancer and comorbidities among American Indian and Alaska Native people
了解美洲印第安人和阿拉斯加原住民的癌症和合并症
  • 批准号:
    10722119
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
Urban American Indian/Alaska Native Cultural Eating Values and Behaviors: Community-based, mixed methods research to inform a holistic and culturally-informed diabetes prevention intervention program
城市美洲印第安人/阿拉斯加原住民文化饮食价值观和行为:基于社区的混合方法研究,为全面且文化丰富的糖尿病预防干预计划提供信息
  • 批准号:
    10679529
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
Planning Grant: Moving Forward Together - Transforming Arctic Geosciences for Alaska Native Sovereignty and Science
规划拨款:共同前进 - 为阿拉斯加原住民主权和科学转变北极地球科学
  • 批准号:
    2228064
  • 财政年份:
    2023
  • 资助金额:
    $ 395.62万
  • 项目类别:
    Standard Grant
Alaska Native Communities Advancing Vaccine Uptake
阿拉斯加原住民社区促进疫苗接种
  • 批准号:
    10504537
  • 财政年份:
    2022
  • 资助金额:
    $ 395.62万
  • 项目类别:
Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: an RCT
基于阿拉斯加原住民家庭的戒烟经济激励干预措施:随机对照试验
  • 批准号:
    10612408
  • 财政年份:
    2022
  • 资助金额:
    $ 395.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了